搜索医生

Kristen B. McCullough, Pharm.D., R.Ph.

  1. Pharmacist

地点

  1. Rochester, Minnesota

语言

English

Kristen McCullough, Pharm.D., is a hematology clinical pharmacy specialist with interest in acute leukemias, chronic myeloid leukemia, myeloproliferative disorders, and allogeneic hematopoietic stem cell transplant. Her clinic time is devoted to providing patient-centered, collaborative services focused on medication appropriateness, effectiveness, safety, and adherence.

Dr. McCullough also serves her profession through committee participation with the Hematology/Oncology Pharmacists Association (HOPA) and the Bone Marrow Transplant Clinical Trial Network (BMT CTN).

  • Acute myeloid and lymphoblastic leukemia
  • Allogeneic bone marrow transplantation
  • Myelodysplastic syndromes
  • Myeloproliferative neoplasms
  • Chronic myeloid leukemia
  1. 2023
    Master of Science - Pharmacy Administration and LeadershipSchool of Pharmacy, University of North Carolina, Chapel Hill
  2. 2011
    Postdoctoral Training - PGY2 Oncology Pharmacy Residency at Mayo ClinicAmerican Society of Health-System Pharmacists
  3. 2010
    Postdoctoral Training - PGY1 Pharmacy Practice Residency at Mayo ClinicAmerican Society of Health-System Pharmacists
  4. 2009
    Pharm DMidwestern University College of Pharmacy - Glendale
  5. 2006
    BA - BiologyUniversity of Minnesota

Certifications

  1. 2012
    Oncology PharmacyBoard of Pharmacy Specialties
  2. 2011
    PharmacotherapyBoard of Pharmacy Specialties

Awards and honors

  1. 2012
    2012 New Preceptor of the YearMayo Clinic in Rochester
  2. 2010
    Chief Pharmacy ResidentMayo School of Health Sciences
  3. 2009
    Natural Medicines Comprehensive Database Recognition AwardNatural Medicines
  4. 2009
    Summa Cum LaudeMidwestern University College of Pharmacy
  5. 2008
    Rho ChiNational Academic Honor Society in Pharmacy

Professional memberships

  1. 2021 - present
    Hematology Oncology Pharmacy Association
  2. 2020 - 2021
    Hematology Oncology Pharmacy Association
  3. 2020 - present
    American Society of Hematology
  4. 2020
    Bone and Marrow Transplant Clinical Trials Network (BMT CTN)
  5. 2019 - present
    PGY2 Oncology Residency Advisory Subcommittee - Recruitment/Selection
  6. 2019 - present
    Practice Subcommittee, Acute Leukemia/Myelodysplastic Syndrome Disease Oriented Group, Division of Hematology
  7. 2019 - present
    Acute Leukemia/Myelodysplastic Syndrome Disease Oriented Group, Division of Hematology, Department of Internal Medicine
  8. 2019 - present
    Acute Leukemia/Myelodysplastic Syndrome Disease Oriented Group, Division of Hematology, Department of Internal Medicine
  9. 2019 - 2020
    Bone and Marrow Transplant Clinical Trials Network (BMT CTN)
  10. 2018 - 2020
    Hematology Oncology Pharmacy Association
  11. 2018 - present
    Acute Leukemia/Myelodysplastic Syndrome Disease Oriented Group, Division of Hematology, Department of Internal Medicine
  12. 2017 - 2021
    Hematology Oncology Pharmacy Association
  13. 2016 - present
    American Society of Bone Marrow Transplant
  14. 2016
    Hematology/Oncology Chemotherapy Order Set Standardization
  15. 2016 - present
    Lymphoma Etumor Board
  16. 2015 - 2016
    Hematology Oncology Pharmacy Association
  17. 2014 - 2018
    Mayo Clinic Scientific Review Committee - A
  18. 2014 - present
    Hematology Clinical Practice Committee, Division of Hematology, Department of Internal Medicine
  19. 2010 - present
    Hematology Oncology Pharmacy Association
  20. 2009 - present
    American College of Clinical Pharmacy

Publications